From disease to aeronautics: Centre earns extra 9.8 million for free radical research
25 Feb 09
In a recent announcement, the Australian Research Council (ARC) approved an extension to grant funding for the Free Radical Chemistry Centre at Bio21 Institute that will enable it to continue its research to the end of 2013 and beyond.
Under the funding, new initiatives will include:
- establishing high tech equipment facilities not previously present in Australia that will complement supercomputer studies of radical chemistry reactions;
- developing pharmaceutical to treat pain and inflammatory diseases such as cardiovascular disease, rheumatoid arthritis and asthma;
- surface coating technologies to protect building, automotive, aeronautical and cultural materials from free radical damage;
- technology to address climate change and energy requirements, especially in the area of environmentally friendly fertiliser production.
The Centre is already responsible for numerous significant discoveries. Read the University of Melbourne Media Release 25 February 2009.